Rapid Micro Biosystems (RPID) Change in Receivables (2020 - 2026)

Rapid Micro Biosystems has disclosed Change in Receivables across 7 years of filings, most recently posting $3.2 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at $3.2 million, up 207.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (up 561.0% YoY), and the FY2025 annual result was -$4.4 million, down 320.79% from the prior year.
• Change in Receivables came in at $3.2 million for Q1 2026 at Rapid Micro Biosystems, up from -$2.3 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $3.8 million in Q4 2024 to a low of -$3.0 million in Q1 2025.
• The 5-year median for Change in Receivables is $142000.0 (2023), against an average of $80000.0.
• Across the five-year window, Change in Receivables jumped 71100.0% in 2022 and plunged 878.41% in 2023, its largest moves.
• Rapid Micro Biosystems' Change in Receivables stood at $710000.0 in 2022, then surged by 128.87% to $1.6 million in 2023, then jumped by 132.55% to $3.8 million in 2024, then sank by 160.81% to -$2.3 million in 2025, then soared by 240.69% to $3.2 million in 2026.
• The last three Change in Receivables figures came in at $3.2 million (Q1 2026), -$2.3 million (Q4 2025), and -$618000.0 (Q3 2025), per Business Quant data.